Abram Scientific Awarded Up To $8.3 Million under a DARPA Contract to Advance Rapid, Portable Blood Coagulation Diagnostics for Trauma Care

By Eric G •
MENLO PARK, Calif., Oct. 13, 2026 — Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, today announced that it has been awarded a contract of up to $8.3 million from the Defense Advanced Research Projects Agency (DARPA) to advance its rapid, handheld blood coagulation testing platform CoagCare™ for use in trauma settings. […]
Related Topics:
abram scientific awarded $8.3 million under darpa contract advance rapid